Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Scalar Diversity, Negative Strengthening, and Adjectival Semantics.

Gotzner N, Solt S, Benz A.

Front Psychol. 2018 Sep 12;9:1659. doi: 10.3389/fpsyg.2018.01659. eCollection 2018.

2.

West Nile virus host-vector-pathogen interactions in a colonial raptor.

Soltész Z, Erdélyi K, Bakonyi T, Barna M, Szentpáli-Gavallér K, Solt S, Horváth É, Palatitz P, Kotymán L, Dán Á, Papp L, Harnos A, Fehérvári P.

Parasit Vectors. 2017 Sep 29;10(1):449. doi: 10.1186/s13071-017-2394-z.

3.

TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner.

Soares KC, Rucki AA, Kim V, Foley K, Solt S, Wolfgang CL, Jaffee EM, Zheng L.

Oncotarget. 2015 Dec 15;6(40):43005-15. doi: 10.18632/oncotarget.5656.

4.

Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells.

Kouo T, Huang L, Pucsek AB, Cao M, Solt S, Armstrong T, Jaffee E.

Cancer Immunol Res. 2015 Apr;3(4):412-23. doi: 10.1158/2326-6066.CIR-14-0150. Epub 2015 Feb 17.

5.

Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.

Le DT, Wang-Gillam A, Picozzi V, Greten TF, Crocenzi T, Springett G, Morse M, Zeh H, Cohen D, Fine RL, Onners B, Uram JN, Laheru DA, Lutz ER, Solt S, Murphy AL, Skoble J, Lemmens E, Grous J, Dubensky T Jr, Brockstedt DG, Jaffee EM.

J Clin Oncol. 2015 Apr 20;33(12):1325-33. doi: 10.1200/JCO.2014.57.4244. Epub 2015 Jan 12.

6.

Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation.

Lutz ER, Wu AA, Bigelow E, Sharma R, Mo G, Soares K, Solt S, Dorman A, Wamwea A, Yager A, Laheru D, Wolfgang CL, Wang J, Hruban RH, Anders RA, Jaffee EM, Zheng L.

Cancer Immunol Res. 2014 Jul;2(7):616-31. doi: 10.1158/2326-6066.CIR-14-0027. Epub 2014 Jun 18.

7.

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.

Le DT, Lutz E, Uram JN, Sugar EA, Onners B, Solt S, Zheng L, Diaz LA Jr, Donehower RC, Jaffee EM, Laheru DA.

J Immunother. 2013 Sep;36(7):382-9. doi: 10.1097/CJI.0b013e31829fb7a2.

8.

Worldwide phylogenetic relationship of avian poxviruses.

Gyuranecz M, Foster JT, Dán Á, Ip HS, Egstad KF, Parker PG, Higashiguchi JM, Skinner MA, Höfle U, Kreizinger Z, Dorrestein GM, Solt S, Sós E, Kim YJ, Uhart M, Pereda A, González-Hein G, Hidalgo H, Blanco JM, Erdélyi K.

J Virol. 2013 May;87(9):4938-51. doi: 10.1128/JVI.03183-12. Epub 2013 Feb 13.

9.

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.

Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru D.

Ann Surg. 2011 Feb;253(2):328-35. doi: 10.1097/SLA.0b013e3181fd271c.

10.

Abstract categories or limited-scope formulae? The case of children's determiners.

Valian V, Solt S, Stewart J.

J Child Lang. 2009 Sep;36(4):743-78. doi: 10.1017/S0305000908009082. Epub 2009 Jan 5.

PMID:
19123961
11.

Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation.

Laheru D, Lutz E, Burke J, Biedrzycki B, Solt S, Onners B, Tartakovsky I, Nemunaitis J, Le D, Sugar E, Hege K, Jaffee E.

Clin Cancer Res. 2008 Mar 1;14(5):1455-63. doi: 10.1158/1078-0432.CCR-07-0371.

Supplemental Content

Support Center